ph-PSL (n = 70) | Control (n = 61) | P-value | |
---|---|---|---|
Age, years† | 46.9 ± 17.4 | 51.3 ± 13.9 | 0.115 |
Sex, n, male/female | 21/49 | 20/41 | 0.732 |
Preoperative%FVC† | 92.4 ± 18.4 | 99.5 ± 18.9 | 0.037* |
Preoperative FEV 1.0%† | 85.2 ± 10.2 | 81.4 ± 6.9 | 0.017* |
Initial MGFA Class I/IIA/IIB/IIIA/IIIB, n | 0/28/17/9/16 | 25/29/5/1/1 | |
Initial MGFA Class I + IIA/IIB + IIIA + IIIB, n | 28/42 | 54/7 | <0.001* |
Initial achR-Ab, nmol/l† | 62.5 ± 98.4 | 93.0 ± 310.3 | 0.456 |
Preoperative anti-ChE, yes/no | 47/23 | 33/28 | 0.127 |
Preoperative tacrolimus, yes/no | 3/67 | 0/61 | 0.248 |
Thymoma, yes/no | 21/49 | 27/34 | 0.091 |
Surgical approach, thoracotomy /VATS | 54/16 | 52/9 | 0.272 |